Iovance Biotherapeutics, Inc. (IOVA)
2.36
+0.14
(+6.31%)
USD |
NASDAQ |
Jan 16, 16:00
2.37
+0.01
(+0.42%)
After-Hours: 20:00
Iovance Biotherapeutics Profit Margin (Quarterly): -135.3% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Lantheus Holdings, Inc. | 7.23% |
| Intellia Therapeutics, Inc. | -735.2% |
| Perspective Therapeutics, Inc. | -12.43K% |
| Electromed, Inc. | 12.65% |
| InfuSystem Holdings, Inc. | 6.19% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -54.43% |
| Return on Assets | -42.48% |
| Return on Invested Capital | -50.34% |
| Gross Profit Margin (Quarterly) | 29.61% |
| Operating Margin (Quarterly) | -133.1% |
| Return on Net Operating Assets | -68.80% |